Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial

International Journal of Cardiology

Volumn 241, Issue , 2017, Pages 35-40

  Damluji, Abdulla A ^a,b   Cohen, Erin R ^c   Moscucci, Mauro ^a   Myerburg, Robert J ^c   Cohen, Mauricio G ^c   Brooks, Maria M ^d   Rich, Michael W ^e   Forman, Daniel E ^f,g  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BARI 2D; Diabetes mellitus; Elderly; Insulin; Ischemic heart disease

Indexed keywords

AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INSULIN PROVISION THERAPY; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; STABLE ISCHEMIC HEART DISEASE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; METABOLISM; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

INSULIN;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COHORT STUDIES; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; MALE; MORTALITY; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85019723199     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.03.048     Document Type: Article

References (23)

1. Selvin, E., Coresh, J., Brancati, F.L., The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 29 (2006), 2415–2419.
2. Kirkman, M.S., Briscoe, V.J., Clark, N., Florez, H., Haas, L.B., Halter, J.B., et al. Diabetes in older adults. Diabetes Care 35 (2012), 2650–2664.
3. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–322.
4. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129 (2014), e28–e292.
5. Damluji, A.A., Ramireddy, A., Otalvaro, L., Forman, D.E., Secondary cardiovascular prevention in older adults: an evidence based review. J. Geriatr. Cardiol. 12 (2015), 459–464.
6. Fleg, J.L., Forman, D.E., Berra, K., Bittner, V., Blumenthal, J.A., Chen, M.A., et al. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation 128 (2013), 2422–2446.
7. Kirkman, M.S., Briscoe, V.J., Clark, N., Florez, H., Haas, L.B., Halter, J.B., et al. Diabetes in older adults: a consensus report. J. Am. Geriatr. Soc. 60 (2012), 2342–2356.
8. Brooks, M.M., Frye, R.L., Genuth, S., Detre, K.M., Nesto, R., Sobel, B.E., et al. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am. J. Cardiol. 97 (2006), 9G–19G.
9. Group BDS, Frye, R.L., August, P., Brooks, M.M., Hardison, R.M., Kelsey, S.F., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N. Engl. J. Med. 360 (2009), 2503–2515.
10. Fitzmaurice, G.M.L.N., Ware, J.H., Applied Longitudinal Analysis. second ed., August 30, 2011, Wiley.
11. Soe, K., Sacerdote, A., Karam, J., Bahtiyar, G., Management of type 2 diabetes mellitus in the elderly. Maturitas 70 (2011), 151–159.
12. Kim, K.S., Kim, S.K., Sung, K.M., Cho, Y.W., Park, S.W., Management of type 2 diabetes mellitus in older adults. Diabetes Metab. J. 36 (2012), 336–344.
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352, 1998, 837–853.
14. Lofgren, U.B., Rosenqvist, U., Lindstrom, T., Hallert, C., Nystrom, F.H., Diabetes control in Swedish community dwelling elderly: more often tight than poor. J. Intern. Med. 255 (2004), 96–101.
15. Reaven, G.M., Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988), 1595–1607.
16. Groop, P.H., Forsblom, C., Thomas, M.C., Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat. Clin. Pract. Endocrinol. Metab. 1 (2005), 100–110.
17. Abbatecola, A.M., Paolisso, G., Diabetes care targets in older persons. Diabetes Res. Clin. Pract. 86:Suppl. 1 (2009), S35–S40.
18. Magee, M.F., Isley, W.L., Investigators, B.D.T., Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am. J. Cardiol. 97 (2006), 20G–30G.
19. Masoudi, F.A., Inzucchi, S.E., Wang, Y., Havranek, E.P., Foody, J.M., Krumholz, H.M., Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 111 (2005), 583–590.
20. Berlie, H.D., Garwood, C.L., Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann. Pharmacother. 44 (2010), 712–717.
21. Dormandy, J.A., Charbonnel, B., Eckland, D.J., Erdmann, E., Massi-Benedetti, M., Moules, I.K., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005), 1279–1289.
22. Home, P.D., Pocock, S.J., Beck-Nielsen, H., Curtis, P.S., Gomis, R., Hanefeld, M., et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 373 (2009), 2125–2135.
23. Kernan, W.N., Viscoli, C.M., Furie, K.L., Young, L.H., Inzucchi, S.E., Gorman, M., et al. Pioglitazone after ischemic stroke or transient ischemic attack. N. Engl. J. Med. 374 (2016), 1321–1331.